BII News - Proxi Biotech wins the BII Acceleration Award

Proxi Biotech wins the BII Acceleration Award

Proxi Biotech wins the BII Acceleration Award

Proxi Biotech is the winner of the BII Acceleration Award. On May 29, 2019, they received the honor on stage at the BII DemoDay in front of an audience of 150 people from the life science ecosystem.

The four start-ups that graduated the three months long Business Acceleration Academy program pitched their projects on stage and a panel of deal takers commented on each start-up, but it was up to the audience to pick the winner.

Proxi Biotech is founded by René Jørgensen, Aria Aminzadeh and Kasper G. Ørtenblad. The team is trying to solve the problem of antimicrobial infections with a vaccine and it was René Jørgensen who came up with the idea to efficiently deactivate bacterial toxins while preserving their immunogenic properties while Aria came up with a solution for it. Kasper G. Ørtenblad is the company CEO and it was him who pitched on stage at DemoDay.

“To have an entire stage in a movie theater really gave an adrenalin kick and the pitch went well, but we were still a bit surprised and of course extremely pleased when we were announced as the winners.”, says Kasper G. Ørtenblad.

Last year’s winner, Cirqle Biomedical was there to hand over the award. Since their graduation from the Business Acceleration Academy, they have been accepted in the Creation House program with funding of DKK 10M.

Do you want to learn more about the BII programs? Click here.

Watch the live stream from the demo day including the pitch from Proxi Biotech here


More news from BII
Meet the start-ups: PrOxi Biotech
Zach Serber: Customer intimacy is a key element to success


Read our impact report and get acquainted with the progress that BII experienced during 2022

Read more
Impact Report 2022